RO4987655

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO4987655, covering 2015-09-02 to 2015-09-02. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors [Phase 1]